Business Description
Alpha Cognition Inc
NAICS : 541714
SIC : 3741
ISIN : CA02074J2048
Share Class Description:
XCNQ:ACOG: Ordinary SharesDescription
Alpha Cognition Inc is a clinical stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurological diseases., such as Alzheimer's disease, and Cognitive Impairment with Mild Traumatic Brain Injury (mTBI) for which there are limited or no treatment options. The Company is focused on the development of ALPHA-1062 for the treatment of mild-to-moderate Alzheimer's disease.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.15 | |||||
| Equity-to-Asset | -1.92 | |||||
| Debt-to-Equity | -0.26 | |||||
| Debt-to-EBITDA | -0.09 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -16.7 | |||||
| 3-Year EPS without NRI Growth Rate | 3.5 | |||||
| 3-Year FCF Growth Rate | 2.8 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 29.84 | |||||
| 9-Day RSI | 35.54 | |||||
| 14-Day RSI | 39.01 | |||||
| 6-1 Month Momentum % | 100 | |||||
| 12-1 Month Momentum % | 225 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.73 | |||||
| Quick Ratio | 0.73 | |||||
| Cash Ratio | 0.53 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -31.6 | |||||
| Shareholder Yield % | -12.14 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -501.38 | |||||
| ROIC % | -540.66 | |||||
| ROC (Joel Greenblatt) % | -485184.21 | |||||
| ROCE % | -6275.36 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -5.51 | |||||
| EV-to-EBITDA | -5.55 | |||||
| EV-to-FCF | -8.79 | |||||
| Earnings Yield (Greenblatt) % | -18.14 | |||||
| FCF Yield % | -11.52 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Alpha Cognition Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | |||
| EPS (TTM) (C$) | -0.188 | ||
| Beta | 3.37 | ||
| Volatility % | 97.49 | ||
| 14-Day RSI | 39.01 | ||
| 14-Day ATR (C$) | 0.042487 | ||
| 20-Day SMA (C$) | 0.707 | ||
| 12-1 Month Momentum % | 225 | ||
| 52-Week Range (C$) | 0.19 - 0.99 | ||
| Shares Outstanding (Mil) | 149.93 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Alpha Cognition Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Alpha Cognition Inc Stock Events
| Event | Date | Price(C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Alpha Cognition Inc Frequently Asked Questions
What is Alpha Cognition Inc(XCNQ:ACOG)'s stock price today?
The current price of XCNQ:ACOG is C$0.65. The 52 week high of XCNQ:ACOG is C$0.99 and 52 week low is C$0.19.
When is next earnings date of Alpha Cognition Inc(XCNQ:ACOG)?
The next earnings date of Alpha Cognition Inc(XCNQ:ACOG) is .
Does Alpha Cognition Inc(XCNQ:ACOG) pay dividends? If so, how much?
Alpha Cognition Inc(XCNQ:ACOG) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers